January 06, 2025 09:09 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir

Laurus Labs signs agreement with MPP for manufacturing Molnupiravir

Jan 22, 2022, at 03:12 am

Mumbai/UNI: Hyderabad-based Laurus Labs Limited on Friday said that it has signed an agreement with MPP (Medicine Patent Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.

MSN Labs initiates Phase-III clinical trials for COVID-19 treatment drug

MSN Labs initiates Phase-III clinical trials for COVID-19 treatment drug

May 25, 2021, at 08:49 pm

Hyderabad/UNI: MSN Laboratories Private Limited, the front-runner in introducing various drugs in the treatment of COVID-19 and its complications, on Tuesday announced that it is initiating phase III clinical trials of ‘Molnupiravir’ capsules for the treatment of COVID-19 in India.